Firstly, the main aim of this study is to address if Aco2 is decreased in brains of different HD mouse models and peripheral blood of HD patients, and if Aco2 activity correlates with disease severity to serve as a potential biomarker, but the underlying mechanism is not investigated, which warrants more studies to explore further in the future. Here, ACO2 is linked to Huntington disease.